Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMQUFNY)

Drug Name

ARM210 Drug Info

Synonyms

Arm-210; UNII-1033GN605L; 1033GN605L; Rycal dmd; SCHEMBL15326996; ARM-210; JIGDAUOKKYKRKO-UHFFFAOYSA-N; s48168; S-48168; 4-((7-Methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl)benzoic acid; Benzoic acid, 4-((2,3-dihydro-7-methoxy-1,4-benzothiazepin-4(5H)-yl)methyl)-; 4-((7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)methyl)benzoic acid; 1467605-57-7

Indication

Disease Entry	ICD 11	Status	REF
Duchenne dystrophy	8C70	Phase 1	[1]

Cross-matching ID

PubChem CID: 71761628
CAS Number: CAS 1467605-57-7
TTD Drug ID: DMQUFNY

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Ryanodine receptor (RYR)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Dantrolene	DM1D8XY	Hyperthermia	MG26	Approved	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Ryanodine receptor (RYR)	TT9YXM1	NOUNIPROTAC	Modulator	[1]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.